D. E. Shaw & Co., Inc. Kodiak Sciences Inc. Transaction History

D. E. Shaw & Co., Inc.

$122 Billion
Q4 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 852,076 shares of KOD stock, worth $4.04 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

852,076

Previous 918,760 7.26%

Holding current value

$4.04 Million

Previous $2.4 Million 253.69%

% of portfolio

0.01%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$2.6 - $10.9 $173,378 - $726,855	-66,684 Reduced 7.26%	852,076 $8.48 Million
Q3 2024 Nov 14, 2024	SELL	$2.2 - $3.25 $58,062 - $85,774	-26,392 Reduced 2.79%	918,760 $2.4 Million
Q2 2024 Aug 14, 2024	SELL	$2.29 - $4.48 $227,850 - $445,751	-99,498 Reduced 9.52%	945,152 $2.22 Million
Q1 2024 May 15, 2024	SELL	$3.01 - $7.45 $494,612 - $1.22 Million	-164,323 Reduced 13.59%	1,044,650 $5.49 Million
Q4 2023 Feb 14, 2024	BUY	$1.4 - $3.24 $297,976 - $689,601	212,840 Added 21.37%	1,208,973 $3.68 Million
Q3 2023 Nov 14, 2023	BUY	$1.8 - $7.49 $13,384 - $55,695	7,436 Added 0.75%	996,133 $1.79 Million
Q2 2023 Aug 14, 2023	SELL	$4.3 - $9.48 $399,912 - $881,668	-93,003 Reduced 8.6%	988,697 $6.82 Million
Q1 2023 May 15, 2023	SELL	$4.81 - $8.88 $401,885 - $741,941	-83,552 Reduced 7.17%	1,081,700 $6.71 Million
Q4 2022 Feb 14, 2023	BUY	$6.52 - $8.05 $1.17 Million - $1.45 Million	180,183 Added 18.29%	1,165,252 $8.34 Million
Q3 2022 Nov 14, 2022	BUY	$7.57 - $12.5 $11,370 - $18,775	1,502 Added 0.15%	985,069 $7.62 Million
Q2 2022 Aug 15, 2022	SELL	$5.04 - $9.48 $71,855 - $135,156	-14,257 Reduced 1.43%	983,567 $7.52 Million
Q1 2022 May 16, 2022	BUY	$7.09 - $89.45 $7.05 Million - $89 Million	994,647 Added 31307.74%	997,824 $7.7 Million
Q4 2021 Feb 14, 2022	SELL	$80.85 - $128.49 $591,336 - $939,775	-7,314 Reduced 69.72%	3,177 $269,000
Q3 2021 Nov 15, 2021	BUY	$81.97 - $106.94 $859,947 - $1.12 Million	10,491 New	10,491 $1.01 Million
Q2 2021 Aug 16, 2021	SELL	$77.2 - $126.54 $879,385 - $1.44 Million	-11,391 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$110.45 - $164.47 $1.26 Million - $1.87 Million	11,391 New	11,391 $1.29 Million
Q4 2020 Feb 16, 2021	SELL	$60.78 - $154.03 $1.04 Million - $2.63 Million	-17,055 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$45.05 - $59.27 $94,154 - $123,874	-2,090 Reduced 10.92%	17,055 $1.01 Million
Q2 2020 Aug 14, 2020	SELL	$42.74 - $66.25 $187,500 - $290,638	-4,387 Reduced 18.64%	19,145 $1.04 Million
Q1 2020 May 15, 2020	SELL	$38.18 - $73.95 $3.6 Million - $6.97 Million	-94,309 Reduced 80.03%	23,532 $1.12 Million
Q4 2019 Feb 14, 2020	BUY	$13.9 - $76.65 $1.64 Million - $9.03 Million	117,841 New	117,841 $8.48 Million

Others Institutions Holding KOD

# of Institutions

109

Shares Held

40.9M

Call Options Held

28.4K

Put Options Held

21.2K

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $247M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account